French retrospective multicentric study of neonatal hemochromatosis: Importance of autopsy and autoimmune maternal manifestations

Pediatric and Developmental Pathology

Volumn 15, Issue 6, 2012, Pages 450-470

  Collardeau Frachon, Sophie ^a   Heissat, Sophie ^b   Bouvier, Raymonde ^a   Fabre, Monique ^c   Baruteau, Julien ^d   Broue, Pierre ^d   Cordier, Marie Pierre ^b   Debray, Dominique ^e   Debiec, Hanna ^f   Ronco, Pierre ^f   Guigonis, Vincent ^g  

^a UNIVERSITÉ LYON 1   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d CHU PURPAN   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f HÔPITAL TENON   (France)

^g LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Alloimmunization; Autoimmune diseases; Fetus; Histology; Liver diseases; Neonatal hemochromatosis

Indexed keywords

AUTOANTIBODY;

ARTICLE; AUTOIMMUNE DISEASE; AUTOPSY; CLINICAL ARTICLE; DOWN SYNDROME; FEMALE; HEMOCHROMATOSIS; HISTOPATHOLOGY; HUMAN; IRON METABOLISM DISORDER; IRON STORAGE; KIDNEY TUBULE DISORDER; LEIOMYOMA; LIVER FAILURE; LIVER FIBROSIS; LIVER HEMOSIDEROSIS; MALE; MULTICENTER STUDY; NEWBORN; NEWBORN DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PATHOLOGIST; PHENOTYPE; PLACENTA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALIVARY GLAND; THYROID GLAND;

ADULT; AUTOIMMUNE DISEASES; AUTOPSY; FEMALE; FETAL DISEASES; HEMOCHROMATOSIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; IRON METABOLISM DISORDERS; LIVER CIRRHOSIS; LIVER FAILURE; MALE; MATERNAL-FETAL EXCHANGE; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; SIDEROSIS;

EID: 84873043317     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/12-02-1155-OA.1     Document Type: Article

References (82)

1. Cottier H. U ber ein der Hamochromatose vergleichbares Krankheitsbild bei Neugeborenen. Schweiz Med Wochenschr 1957;87: 39-43.
2. Knisely AS, Magid MS, Dische MR, Cutz E. Neonatal haemochromatosis. Birth Defects 1987;23:75-102.
3. Silver MM, Beverley DW, Valberg LS, Cutz E, Phillips MJ, Shaheed WA. Perinatal hemochromatosis: clinical, morphologic, and quantitative iron studies. Am J Pathol 1987;128:538-554.
4. Witzleben CL, Uri A. Perinatal haemochromatosis: entity or end result? Hum Pathol 1989;20:335-340.
5. Moerman P, Pauwels P, Vandenberghe K, et al. Neonatal haemochromatosis. Histopathology 1990;17:345-351.
6. Dalhoj J, Kiaer H, Wiggers P, Grady RW, Jones RL, Knisely AS. Iron storage disease in parents and sibs of infants with neonatal hemochromatosis: 30-year follow-up. Am J Med Genet 1990;37: 342-345.
7. Ferrell L, Schmidt K, Packman S. Neonatal hemochromatosis: genetic counseling based on retrospective pathologic diagnosis. Am J Med Genet 1992;44:429-433.
8. Silver MM, Valberg LS, Cutz E, Lines LD, Phillips MJ. Hepatic morphology and iron quantitation in perinatal hemochromatosis: comparison with a large perinatal control population, including cases with chronic liver disease. Am J Pathol 1993;143:1312-1325.
9. Verloes A, Temple IK, Hubert AF, et al. Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers. J Med Genet 1996;33:444-449.
10. Kassem E, Dolfin T, Litmanowitz I, Regev R, Arnon S, Kidron D. Familial perinatal hemochromatosis: a disease that causes recurrent non-immune hydrops. J Perinat Med 1999;27:122-127.
11. Kelly AL, Lunt PW, Rodrigues F, et al. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet 2001;38:599-610.
12. Murray KF, Kowdley KV. Neonatal hemochromatosis. Pediatrics 2001;108:960-964.
13. Knisely AS, Mieli-Vergani G, Whitington PF. Neonatal hemochromatosis. Gastroenterol Clin North Am 2003;32:877-889, vi-vi.i.
14. Goyal R, Pattari SK, Kakkar N, Radotra BD, Narang A. Pathology teach and tell: neonatal hemochromatosis with massive hepatic necrosis. Fetal Pediatr Pathol 2004;23:345-350.
15. Whitington PF, Kelly S, Ekong UD. Neonatal hemochromatosis: fetal liver disease leading to liver failure in the fetus and newborn. Pediatr Transplant 2005;9:640-645.
16. Ekong UD, Kelly S, Whitington PF. Disparate clinical presentation of neonatal hemochromatosis in twins. Pediatrics 2005;116:e880-e884.
17. Whitington PF. Fetal and infantile hemochromatosis. Hepatology 2006;43:654-660.
18. Pearson L, Bissinger R, Romero KR. Neonatal hemochromatosis: a case report. Adv Neonatal Care 2009;9:72-76.
19. Saenz MS, Van Hove J, Scharer G. Neonatal liver failure: a genetic and metabolic perspective. Curr Opin Pediatr 2010;22:241-245.
20. Whitington PF, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 2004; 364:1690-1698.
21. Whitington PF, Malladi P. Neonatal hemochromatosis: is it an alloimmune disease? J Pediatr Gastroenterol Nutr 2005;40:544-549.
22. Whitington PF. Neonatal hemochromatosis: a congenital alloimmune hepatitis. Semin Liver Dis 2007;27:243-250.
23. Hardy L, Hansen JL, Kushner JP, Knisely AS. Neonatal hemochromatosis: genetic analysis of transferrin-receptor, H-apoferritin, and L-apoferritin loci and of the human leukocyte antigen class I region. Am J Pathol 1990;137:149-153.
24. Whitington PF, Kelly S. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics 2008;121:e1615-e1621.
25. Carrabin N, Cordier MP, Gaucherand P. High-dose immunoglobulin during pregnancy for two patients with risk of recurrent neonatal haemochromatosis. J Gyn Obst Biol Reprod 2007;36:409-412.
26. Pierce LR, Jain N. Risks associated with the use of intravenous immunoglobulin. Transfus Med Rev 2003;17:241-251.
27. Baruteau J, Heissat S, Collardeau-Frachon S, Debray D, Broue P, Guigonis V. Nouveaux concepts dans l'hemochromatose perinatale. Arch Pediatr 2012;19:755-761.
28. Hayes AM, Jaramillo D, Levy HL, Knisely AS. Neonatal hemochromatosis: diagnosis with MR imaging. AJR Am J Roentgenol 1992;159:623-625.
29. Oddone M, Bellini C, Bonacci W, Bartocci M, Toma P, Serra G. Diagnosis of neonatal hemochromatosis with MR imaging and duplex Doppler sonography. Eur Radiol 1999;9:1882-1885.
30. Gandon Y, Olivie D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357-362.
31. Knisely AS, O'Shea PA, Stocks JF, Dimmick JE. Oropharyngeal and upper respiratory tract mucosal-gland siderosis in neonatal hemochromatosis: an approach to biopsy diagnosis. J Pediatr 1988;113:871-874.
32. Smith SR, Shneider BL, Magid M, Martin G, Rothschild M. Minor salivary gland biopsy in neonatal hemochromatosis. Arch Otolaryngol Head Neck Surg 2004;130:760-763.
33. Chan KC, Edelman M, Fantasia JE. Labial salivary gland involvement in neonatal hemochromatosis: a report of 2 cases and review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:e27-e30.
34. Magliocca KR, Lewis EL, Bhattacharyya I, Cohen DM, Dixon LR. Labial salivary gland biopsy in the investigation of neonatal hemochromatosis. J Oral Maxillofac Surg 2011;69:2592-2594.
35. Knisely AS. Iron and pediatric liver disease. Semin Liver Dis 1994; 14:229-235.
36. Burton BK. Inborn errors of metabolism in infancy: a guide to diagnosis. Pediatrics 1998;102:E69.
37. Sergi C, Himbert U, Weinhardt F, et al. Hepatic failure with neonatal tissue siderosis of hemochromatotic type in an infant presenting with meconium ileus: case report and differential diagnosis of the perinatal iron storage disorders. Pathol Res Pract 2001;197:699-709; discussion 11-13.
38. Broue P, Baruteau J. Diagnosis and management of metabolic liver failure in children. Arch Pediatr 2009;16:640-642.
39. Shanmugam NP, Bansal S, Greenough A, Verma A, Dhawan A. Neonatal liver failure: aetiologies and management-state of the art. Eur J Pediatr 2011;170:573-581.
40. Kershisnik MM, Knisely AS, Sun CC, Andrews JM, Wittwer CT. Cytomegalovirus infection, fetal liver disease, and neonatal hemochromatosis. Hum Pathol 1992;23:1075-1080.
41. Metzman R, Anand A, DeGiulio PA, Knisely AS. Hepatic disease associated with intrauterine parvovirus B19 infection in a newborn premature infant. J Pediatr Gastroenterol Nutr 1989;9:112-114.
42. Shneider BL, Setchell KD, Whitington PF, Neilson KA, Suchy FJ. Delta 4-3-oxosteroid 5 beta-reductase deficiency causing neonatal liver failure and hemochromatosis. J Pediatr 1994;124:234-238.
43. Clayton PT. Delta 4-3-oxosteroid 5 beta-reductase deficiency and neonatal hemochromatosis. J Pediatr 1994;125:845-846.
44. Siafakas CG, Jonas MM, Perez-Atayde AR. Abnormal bile acid metabolism and neonatal hemochromatosis: a subset with poor prognosis. J Pediatr Gastroenterol Nutr 1997;25:321-326.
45. Gonzales E, Cresteil D, Baussan C, Dabadie A, Gerhardt MF, Jacquemin E. SRD5B1 (AKR1D1) gene analysis in delta(4)-3-oxosteroid 5beta-reductase deficiency: evidence for primary genetic defect. J Hepatol 2004;40:716-718.
46. Verhoeven NM, Huck JH, Roos B, et al. Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway. Am J Hum Genet 2001;68:1086-1092.
47. Valayannopoulos V, Verhoeven NM, Mention K, et al. Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multiorgan disease. J Pediatr 2006;149:713-717.
48. Sokol RJ, Treem WR. Mitochondria and childhood liver diseases. J Pediatr Gastroenterol Nutr 1999;28:4-16.
49. Lee WS, Sokol RJ. Mitochondrial hepatopathies: advances in genetics and pathogenesis. Hepatology 2007;45:1555-1565.
50. Labarthe F, Dobbelaere D, Devisme L, et al. Clinical, biochemical and morphological features of hepatocerebral syndrome with mitochondrial DNA depletion due to deoxyguanosine kinase deficiency. J Hepatol 2005;43:333-341.
51. Dimmock DP, Zhang Q, Dionisi-Vici C, et al. Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat 2008;29:330-331.
52. Hanchard N, Shchelochkov OA, Brundage E, Schmitt E, Li F,Wong LJ, Scaglia F. Deoxyguanosine kinase (DGUOK) deficiency presenting as neonatal haemochromatosis. Mol Genet Metab 2010;99:216-217.
53. Pronicka E, Weglewska-Jurkiewicz A, Taybert J, et al. Post mortem identification of deoxyguanosine kinase (DGUOK) gene mutations combined with impaired glucose homeostasis and iron overload features in four infants with severe progressive liver failure. J Appl Genet 2011;52:61-66.
54. Hoogstraten J, de Sa DJ, Knisely AS. Fetal liver disease may precede extrahepatic siderosis in neonatal hemochromatosis. Gastroenterology 1990;98:1699-1701.
55. Pan X, Kelly S, Melin-Aldana H, Malladi P, Whitington PF. Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade. Hepatology 2010;51:2061-2068.
56. Bonilla S, Prozialeck JD, Malladi P, et al. Neonatal iron overload and tissue siderosis due to gestational alloimmune liver disease. J Hepatol 2012;56:1351-1355.
57. Ruchelli ED, Uri A, Dimmick JE, et al. Severe perinatal liver disease and Down syndrome: an apparent relationship. Hum Pathol 1991;22:1274-1280.
58. Cheung PC, NgWF, ChanAK. Neonatal haemochromatosis associated with Down syndrome. J Paediatr Child Health 1995;31:249-252.
59. Neil E, Cortez J, Joshi A, et al. Hepatic failure, neonatal hemochromatosis and porto-pulmonary hypertension in a newborn with trisomy 21: a case report. Ital J Pediatr 2010;18:36-38.
60. Aksoy F, Goksel S, Ilvan S, Dervisog?lu S, Ramazanog?lu R. Congenital generalized infantile myofibromatosis and neonatal hemochromatosis: an autopsy case report. Turk J Pediatr 2000;42:334-337.
61. Pine SR, Guo Q, Yin C, Jayabose S, Druschel CM, Sandoval C. Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood 2007;110:2128-2131.
62. De Vita S, Mulligan C, McElwaine S, et al. Loss-of-function JAK3 mutations in TMD and AMKL of Down syndrome. Br J Haematol 2007;137:337-341.
63. Bale PM, Kan AE, Dorney SF. Renal proximal tubular dysgenesis associated with severe neonatal hemosiderotic liver disease. Pediatr Pathol 1994;14:479-489.
64. Johal JS, Thorp JW, Oyer CE. Neonatal hemochromatosis, renal tubular dysgenesis, and hypocalvaria in a neonate. Pediatr Dev Pathol 1998;1:433-437.
65. Morris S, Akima S, Dahlstrom JE, Ellwood D, Kent A, Falk MC. Renal tubular dysgenesis and neonatal hemochromatosis without pulmonary hypoplasia. Pediatr Nephrol 2004;19:341-344.
66. Bonilla SF, Melin-Aldana H, Whitington PF. Relationship of proximal renal tubular dysgenesis and fetal liver injury in neonatal hemochromatosis. Pediatr Res 2010;67:188-193.
67. Azar D, Bonilla S, Amaro D, Whitington P, Krous H. Reduced angiotensinogen in neonatal hemochromatosis leads to impaired development of proximal renal tubules and compensatory glomerular changes. Lab Invest 2011;91:357A.
68. Valberg LS. Plasma ferritin concentrations: their clinical significance and relevance to patient care. Can Med Assoc J 1980;122:1240-1248.
69. Lee WS, McKiernan PJ, Kelly DA. Serum ferritin level in neonatal fulminant liver failure. Arch Dis Child Fetal Neonatal Ed 2001;85: F226.
70. Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol. 2007;38:1439-1446.
71. Boyd TK, Redline RW. Chronic histiocytic intervillositis: a placental lesion associated with recurrent reproductive loss. Hum Pathol 2000;31:1389-1396.
72. Parizhskaya M, Reyes J, Jaffe R. Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatr Dev Pathol 1999;2:360-366.
73. Senger C, Gonzalez-Crussi F. Histiocytic-phagocytic infiltrates in the liver of an infant: a case clinically simulating perinatal hemochromatosis. J Pediatr Gastroenterol Nutr 1999;29:215-220.
74. Gurgey A, Unal S, Okur H, Orhan D, Yurdakok M. Neonatal primary hemophagocytic lymphohistiocytosis in Turkish children. J Pediatr Hematol Oncol 2008;30:871-876.
75. Nakao T, Shimizu T, Fukushima T, et al. Fatal sibling cases of familial hemophagocytic lymphohistiocytosis (FHL) with MUNC13-4 mutations: case reports. Pediatr Hematol Oncol 2008; 25:171-180.
76. Miquel E, Cavelier B, Bonneau JC, Rouger P. Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn. Transfus Clin Biol 2005;12:45-55.
77. Ronco P, Debiec H, Guigonis V. Mechanisms of disease: alloimmunization in renal diseases. Nat Clin Pract Nephrol 2006; 2:388-397.
78. Kaplan C. Alloimmune thrombocytopenia of the fetus and the newborn. Blood Rev 2002;16:69-72.
79. Schoenlebe J, Buyon JP, Zitelli BJ, Friedman D, Greco MA, Knisely AS. Neonatal hemochromatosis associated with maternal autoantibodies against Ro/SS-A and La/SS-B ribonucleoproteins. Am J Dis Child 1993;147:1072-1075.
80. Burch JM, Sokol RJ, Narkewicz MR, et al. Autoantibodies in mothers of children with neonatal liver disease. J Pediatr Gastroenterol Nutr 2003;37:262-267.
81. Knisely AS, Vergani D. Neonatal hemochromatosis: a re-vision. Hepatology 2010;51:1888-1890.
82. Collardeau-Frachon S, Scoazec JY. Vascular development and differentiation during human liver organogenesis. Anat Rec 2008; 291:614-627.